Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL001032

Drug Information
NameVanoxerine
SynonymsCAS-67469-78-7; NCGC00015300-02; Prestwick3_000386; AR-1B9770; BPBio1_001141; 1-[2-[bis(4-Fluorophenyl)methoxy]ethyl]-4-[3-phenylpropyl]piperazine dihydrochloride; LS-187205; 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine; AKOS003588978; BRD-K32501161-300-03-9; 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine dihydrochloride; NCGC00024581-01; LS-107633; GBR-12909; Vanoxeamine; KBio1_001940; MolPort-003-983-576; GBR 12909 dihydrochloride; NCI60_038175; Piperazine, 1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)-, dihydrochloride; HMS1569M13; NCGC00015300-01; D052_SIGMA; Lopac0_000446; AC1Q3AML; 1-(2 (Bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine di-hcl; NCGC00024581-03; AC1L2XPW; 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride; CID104920; Gbr 12909; S2171_Selleck; Vanoxerine; Vanoxerina [INN-Spanish]; Prestwick0_000386; AB00053750; BRD-K32501161-001-01-7; 67469-69-6; NCGC00024581-02; Prestwick1_000386; NCGC00093862-01; SpecPlus_000900; UNII-90X28IKH43; CID3455; DivK1c_006996; AC1L1FZ5; Prestwick2_000386; Vanoxerine [INN]; CHEMBL543876; Tocris-0421; GBR-12909 dihydrochloride; BSPBio_000571; Lopac-D-052; D-052; 1-(2-(Bis(p-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine; Vanoxerinum; MolPort-002-506-333; Vanoxerinum [INN-Latin]; SPBio_002492; EU-0100446; 1-(2-bis-[4-FLUOROPHENYL]-METHOXYETHYL)-4-(3-PHENYL-2-PROPYL)PIPERAZINE; NCGC00015300-07; I-893; CHEMBL281594; Vanoxerina; Prestwick_664; I 893; Biomol-NT_000010; BPBio1_000629; 1-(2-[bis(4-Fluorophenyl)methoxy]ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride; 67469-78-7
CompanyNational Institute on Drug Abuse
IndicationCocaine addiction
[ICD9: 304.2   ICD10: F14.2]
Terminated in Phase I    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C28H32F2N2O/c29-26-12-8-24(9-13-26)28(25-10-14-27(30)15-11-25)
33-22-21-32-19-17-31(18-20-32)16-4-7-23-5-2-1-3-6-23/h1-3,5-6,8-1
5,28H,4,7,16-22H2
InChIKeyNAUWTFJOPJWYOT-UHFFFAOYSA-N
Canonical SMILESC1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F    
CAS NumberCAS 67469-78-7
FormulaC28H32F2N2O
PubChem Compound IDCID 3455.
PubChem Substance IDSID 211021.
ClinicalTrials.govNCT00218049;
TargetSodium-dependent dopamine transporterBlocker[1]
Ref 1Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs. 2006 Mar;11(1):91-8. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543